Key result
Abdominal obesity in children and adolescents is strongly associated with an atherogenic risk profile and cardiometabolic risk factors, including insulin resistance, dyslipidemia, and hypertension.
Abdominal obesity in children and adolescents is a major driver of early cardiometabolic risk, emphasizing the critical need for early lifestyle interventions to prevent adult cardiovascular disease.
Obesity prevalence has increased worldwide over the last decades and has reached alarming rates in low middle-income countries. Childhood has been affected by this epidemic, leading to premature dramatic health problems. Adipose tissue is currently considered as an endocrine organ modulating an inflammatory state and important metabolic processes (insulin resistance, hypertension, glucose intolerance) leading to consequences of the cardiovascular system. This situation may be worst if the excess of body fat distribution such as abdominal obesity (AO) is involved because it is associated with a more atherogenic risk profile determining the cardiometabolic risks mainly in children and adolescents. Hence, the knowledge regarding the association between AO and cardiometabolic factors aims to prevent and treat the obesity in this young population, avoiding early harmful consequences of adulthood health.
No takes yet. Share an insight, caveat, or question.
Forkert et al. (2016) conducted a review in Abdominal obesity and cardiometabolic risk. Abdominal obesity vs. General obesity or normal weight was evaluated on Cardiometabolic risk factors (glucose metabolism disorders, lipid abnormalities, hypertension, metabolic syndrome). Abdominal obesity in children and adolescents is strongly associated with an atherogenic risk profile and cardiometabolic risk factors, including insulin resistance, dyslipidemia, and hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: